Shankar Biswas, Yashasvi Srivastava, Rahul Falodia, Ayman Hamadttu. "Fruquintinib versus trifluridine-tipiracil plus bevacizumab versus regorafenib in refractory metastatic colorectal cancer: A propensity score–matched real-world analysis.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.19_suppl.134